Department of Obstetrics and Gynecology, Suzhou Hospital, Affiliated Hospital of Medical School, Nanjing University, Suzhou, China.
Department of Obstetrics and Gynecology, Jiangxi Cancer Hospital, The Second Affiliated Hospital of Nanchang Medical College, Jiangxi Clinical Research Center for Cancer, Nanchang, Jiangxi, China.
Pol J Pathol. 2024;75(2):83-96. doi: 10.5114/pjp.2024.139610.
There is growing evidence that the KDM5 family of histone demethylases plays a causal role in human cancer. However, few studies have been reported on the KDM5 family in endometrial carcinoma (EC). Moreover, it was found that there was some correlation between the KDM5 family and FOXO1 in EC. The current study was performed to explore the expressions of KDM5A, KDM5B, and FOXO1 in endometrioid adenocarcinoma detected by immunohistochemistry; paracancer endometrium, simple hyperplastic endometrium, and normal endometrium were used as control groups to explore the possible diagnostic value of KDM5A and KDM5B expression in endometrioid adenocarcinoma, with the aim of evaluating the potential of this marker in predicting the prognosis of endometrioid adenocarcinoma.
越来越多的证据表明,组蛋白去甲基酶 KDM5 家族在人类癌症中起因果作用。然而,关于子宫内膜癌(EC)中 KDM5 家族的研究甚少。此外,研究发现 KDM5 家族与 EC 中的 FOXO1 之间存在一定的相关性。本研究旨在通过免疫组织化学检测探讨 KDM5A、KDM5B 和 FOXO1 在子宫内膜样腺癌中的表达;将癌旁子宫内膜、单纯性增生性子宫内膜和正常子宫内膜作为对照组,探讨 KDM5A 和 KDM5B 表达在子宫内膜样腺癌中的可能诊断价值,旨在评估该标志物在预测子宫内膜样腺癌预后方面的潜力。